StockWatch
·
Biological Products, (No Diagnostic Substances)
ExpansionJun 1, 2026, 09:27 AM

BiomX's Zorronet Expands C5ISR Suite for On-Premise Deployments

AI Summary

BiomX Inc. announced that its Zorronet subsidiary has expanded its autonomous C5ISR suite to support fully secure on-premise, hybrid, and closed-loop deployments. This expansion allows organizations in defense, security, and critical infrastructure to run the full suite locally without relying on the public cloud, addressing regulatory and cybersecurity requirements. The C5ISR market is projected to reach $189 billion by 2030, driven by demand for secure, real-time situational awareness and faster command decision-making.

Key Highlights

  • Zorronet expanded its C5ISR suite to support fully secure on-premise, hybrid, and closed-loop deployments.
  • The expanded offering enables the full C5ISR suite to run inside hardened sites and restricted infrastructure.
  • Addresses growing demand for autonomous command-and-control systems functioning locally without public cloud.
  • The C5ISR market is expected to grow to $189 billion by 2030.
  • The architecture supports autonomous command-and-control, local AI processing, and edge computing.
  • The system integrates with existing security devices like cameras, sensors, drones, and IoT assets.